Characteristic | ELRC group (n = 48) | TLRC group (n = 65) | p value |
---|---|---|---|
Age year, median ± SD (range) | 67.8 ± 8.4 | 66.0 ± 8.9 | 0.283c |
BMI kg/m2, median ± SD (range) | 25.5 ± 3.6 | 26.2 ± 3.6 | 0.313c |
ASA score ≥ 2, no. (%) | 25(52.1) | 38(58.5) | 0.567a |
Previous abdominal surgery, no. (%) | 13 (27.1) | 20 (30.8) | 0.835a |
Preoperative clinical stage | Â | Â | 0.563a |
 Ta Tis | 5 (10.4) | 9 (13.8) |  |
 T1 | 16 (33.3) | 26 (40.0) |  |
 T2 | 27 (56.3) | 30 (46.2) |  |
 TUR-BT, n (%) | 23 (47.9) | 38 (58.5) | 0.340a |
New adjuvant chemotherapy, n (%) | 14 (29.2) | 21 (32.3) | 0.837a |
Operative time, median ± SD, min | 286.5 ± 34.5 | 272.1 ± 35.5 | 0.036b |
Estimated blood loss, mean ± SD, mL | 405.2 ± 173.3 | 383.0 ± 180.0 | 0.517c |
Transfusion rate, no. (%) | 3(6.3) | 5(7.7) | 0.999b |
Interval to flatus, mean ± SD, h | 35.5 ± 9.7 | 42.7 ± 10.8 | 0.0004c |
Interval to solid food, mean ± SD, day | 4.8 ± 1.3 | 6.0 ± 1.7 | 0.0017c |
Length of hospital stay, mean± SD, day | 12.7 ± 2.0 | 14.0 ± 2.7 | 0.0049c |